Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-15

Clinical Trial Update: Growth Hormone Therapy for Wasting in Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 study of recombinant growth hormone for wasting in cystic fibrosis was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (somatropin)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Cystic Fibrosis | Phase 1 | Status: TERMINATED | Results posted: 2013-01-15